These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 983623)

  • 1. [Nigrostriatally induced motor reactions in the rat. I. Rotational behavior and posture asymetry after intracerebral injection of apomorphine and dopamine].
    Westermann KH; Staib AH
    Acta Biol Med Ger; 1976; 35(6):773-80. PubMed ID: 983623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nigrostiatally induced motor reactions in the rat. II. Cholinergic effect on rotational behavior and posture asymetry].
    Westermann KH; Staib AH
    Acta Biol Med Ger; 1976; 35(6):781-6. PubMed ID: 983624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dopamine sensitivity of brain-induced behavior after repeated administration of dopamine agonists and antagonists].
    Westermann KH; Schmidt J
    Biomed Biochim Acta; 1984; 43(7):1027-32. PubMed ID: 6517885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation.
    Oberlander C; Boissier JR
    J Pharmacol; 1983; 14(4):401-4. PubMed ID: 6423905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reduction of apomorphine-induced rotation in rats with additional destruction of the pedunculopontine nucleus contralateral to the unilateral nigrostriatal lesion].
    Kannari K; Maeda T; Matsunaga M; Suda T
    No To Shinkei; 1998 Jan; 50(1):33-7. PubMed ID: 9493196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, fully automated rotometer for the study of turning behavior. Comparison of results under different experimental conditions.
    D'Anna L; Loidl CF; Pecci-Saavedra J; González SA; Soqueff MN; Campastro OJ; Fernández RA
    Acta Physiol Pharmacol Latinoam; 1989; 39(3):255-68. PubMed ID: 2576765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.
    Herrera-Marschitz M; Forster C; Ungerstedt U
    Acta Physiol Scand; 1985 Nov; 125(3):519-27. PubMed ID: 3936338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of apomorphine injection into caudate nucleus on electrical activity of some structures of the rabbit brain.
    Smialowski A
    Pol J Pharmacol Pharm; 1977; 29(5):461-7. PubMed ID: 593964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intrahippocampal administration of dopamine or apomorphine on EEG of limbic structures in the rabbit brain.
    Smialowski A
    Pol J Pharmacol Pharm; 1976; 28(6):579-85. PubMed ID: 1012981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression.
    Duty S; Brotchie JM
    Exp Neurol; 1997 Apr; 144(2):423-32. PubMed ID: 9168843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
    Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M
    Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological disturbances, nigrostriate synapses, and iontophoretic dopamine and apomorphine after haloperidol.
    Zarzecki P; Blake DJ; Somjen GG
    Exp Neurol; 1977 Dec; 57(3):956-70. PubMed ID: 200450
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of nootropic drugs on dopaminergic systems in the CNS.
    Westermann KH; Schmidt J; Bucher U
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):431-6. PubMed ID: 6799944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of supersensitive apomorphine-induced rotational behavior in mice by continuous exposure to apomorphine.
    Winkler JD; Weiss B
    J Pharmacol Exp Ther; 1986 Jul; 238(1):242-7. PubMed ID: 3088260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Involvement of serotoninergic mechanisms in the circling behaviour induced by apomorphine and LSD 25 in rats (author's transl)].
    Jaton AL; Vigouret JM; Dravid A
    J Physiol (Paris); 1981; 77(2-3):405-11. PubMed ID: 7288655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra.
    Satoh H; Satoh Y; Notsu Y; Honda F
    Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.